🔗 Share this article

A shadow economy for unapproved slimming drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on new investigations.

Experimental Treatment Gaining Popularity Online

Retatrutide, which is still in clinical trials, is being promoted by social media influencers for its alleged fat-burning properties. Followers are encouraged to message these profiles directly for source information, while also obtaining discount codes.

Thriving Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of participants share comparison images, injection guides and claims of next-day UK delivery. Sellers market the substance there before redirecting customers to WhatsApp for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable created by US drugmaker Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their body weight. Nicknamed the “triple G”, the substance is being promoted online as the successor to Ozempic.

Medical Professionals Voice Worries

However, physicians and pharmacists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could lead to individuals administering products of uncertain source.

Some experts stated the demand for retatrutide could be connected to the increasing price of approved weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that must not be marketed or distributed for human use under the British medical regulations.

Several influencers attempt to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and supply can still breach pharmaceutical, advertising, and customer regulations, potentially leading to fines, legal action or imprisonment.

Service Response and Content Elimination

Based on the social media company, the service has taken down problematic material and banned associated keywords and search suggestions. The company said it was committed to keeping the service safe and investing in strengthening compliance measures.

Online Trading Activities

Investigations also found groups with up to 9,000 members selling retatrutide using Telegram's integrated search feature, which operates like a online catalog. Typing “retatrutide” immediately displays channels with numerous of members, filled with images of slimming results, positive testimonials and detailed guides for preparing or administering at home.

After minutes of entering one community, a vendor posted contact information, where the majority of transactions take place. The seller sent an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another provided a image of a supposed testing documentation. None asked about body mass, health issues or previous experience.

Product Information and Costs

Within these communities, messages display black plastic parcels with Royal Mail labels, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at residence with sterile water, or pre-filled pens typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it regularly monitored dangerous content on its service including content that encouraged the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Warnings

“People are administering materials they can’t verify. Even if the science behind this drug is valid, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the increase in interest to recent cost increases for authorized slimming medications such as Mounjaro. “With costs increasing, patients are using online platforms. But fake injections are highly risky. You cannot know what’s contained or whether the conditions they were produced in was clean,” she explained.

Her team has previously encountered individuals injured by self-injection from unverified sources. “We recognize the frustration, but buying from messaging apps or communication platforms is taking chances with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from the pharmaceutical company stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority anywhere in the world. “Consequently at this time no one can market [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational product not yet authorized … may subject patients to potentially significant health risks”.